Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): The Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial
<p>Abstract</p> <p>Background</p> <p>18-Fluorodeoxyglucose-PET (<sup>18</sup>F-FDG-PET) can be used for early response assessment in patients with locally advanced adenocarcinomas of the oesophagogastric junction (AEG) undergoing neoadjuvant chemotherapy. It...
Main Authors: | Weichert Wilko, Lordick Florian, Haberkorn Uwe, Weitz Jürgen, Haag Georg M, Stange Annika, von Gall Carl, Lorenzen Sylvie, Abel Ulrich, Debus Jürgen, Jäger Dirk, Münter Marc W |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-06-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/11/266 |
Similar Items
-
Laparoscopic sleeve gastrectomy for oesophago-gastric junction duplication cyst and morbid obesity
by: Gee, Tikfu, et al.
Published: (2020) -
Immune Checkpoint Inhibition in Oesophago-Gastric Carcinoma
by: Anica Högner, et al.
Published: (2021-02-01) -
Optimising Multimodality Treatment of Resectable Oesophago-Gastric Adenocarcinoma
by: Ali Abdulnabi Suwaidan, et al.
Published: (2022-01-01) -
ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS)
by: JV Reynolds, et al.
Published: (2017-06-01) -
PET/CT-tailored treatment of locally advanced oesophago-gastric junction adenocarcinoma: a report on the feasibility of the multicenter GastroPET study
by: Radka Obermannova, et al.
Published: (2021-12-01)